<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We examined whether a 1-year intensive lifestyle intervention (ILI) for <z:hpo ids='HP_0001824'>weight loss</z:hpo> reduced elevated high-sensitivity C-reactive protein (hs-CRP) levels in <z:mp ids='MP_0001261'>obese</z:mp> individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> and identified metabolic and fitness predictors of hs-CRP change </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Look AHEAD (Action for Health in <z:mp ids='MP_0002055'>Diabetes</z:mp>) is an ongoing multicenter clinical trial examining the effects of <z:hpo ids='HP_0001824'>weight loss</z:hpo> achieved through ILI on cardiovascular events and overall mortality in <z:mp ids='MP_0001261'>obese</z:mp>/overweight adults with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We report on 1,759 Look AHEAD participants who had hs-CRP and fitness data at baseline and 1 year </plain></SENT>
<SENT sid="3" pm="."><plain>Subjects were randomly assigned to ILI or to usual care (<z:mp ids='MP_0002055'>diabetes</z:mp> support and education [DSE]) </plain></SENT>
<SENT sid="4" pm="."><plain>ILI involved frequent counseling to increase moderate-intensity exercise to 175 min/week, reduce caloric and saturated fat intake, and change macronutrient composition to improve glycemic control </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: ILI reduced median hs-CRP by 43.6% from baseline to 1 year, compared with a 16.7% reduction with DSE (P&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>ILI <z:hpo ids='HP_0004325'>decreased weight</z:hpo> (8.8%), A1C (0.7%), and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (17%) and increased fitness (19%) and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (7.5%) (P&lt;0.0001 vs. changes with DSE) </plain></SENT>
<SENT sid="7" pm="."><plain>Changes in <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and <z:chebi fb="105" ids="17234">glucose</z:chebi> control with ILI remained independent predictors of hs-CRP change at 1 year (P&lt;0.0001 for each) after adjustment for demographics, smoking, cardiovascular history, <z:chebi fb="0" ids="35664">statin</z:chebi> and thiazolidinedione use, and changes in fitness and <z:chebi fb="23" ids="18059">lipid</z:chebi> control </plain></SENT>
<SENT sid="8" pm="."><plain>Neither <z:chebi fb="0" ids="35664">statin</z:chebi> nor insulin therapy modified the association between ILI and hs-CRP </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: A 1-year lifestyle intervention for <z:hpo ids='HP_0001824'>weight loss</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> was associated with substantial reductions in hs-CRP </plain></SENT>
<SENT sid="10" pm="."><plain>Improved glycemic control and reduced <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> had comparable effects on hs-CRP change </plain></SENT>
</text></document>